SHAILY ENGINEERING PLASTICS LTD.

Shaily Engineering Plastics Ltd has announced the closure of its trading window for designated persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from July 01, 2026, and will reopen 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. The specific date for the board meeting to approve these results will be communicated separately.

Vanita L Nagda has disposed of 10,43,510 equity shares, representing 2.27% of Shaily Engineering Plastics Ltd.'s equity capital, through an open market sale on June 18, 2026. This transaction falls under SEBI's substantial acquisition regulations, requiring disclosure from the seller.

Shaily Engineering Plastics Ltd announces its strategic partner Orbicular Pharmaceutical Technologies, in partnership with its Customer, has launched a generic version of Semaglutide injection in Canada, incorporating Shaily’s proprietary spring-driven ShailyPen Neo™ pen platform. The product is commercially available in India since March 2026 and has received USFDA Tentative Approval. ShailyPen Neo™ is a variable and fixed dose platform offering compatibility with ISO-standard 3 mL cartridges.

Shaily Engineering Plastics Ltd has appointed Mr. Chi Hung Kam as Chief Operating Officer, Healthcare, as a Key Managerial Personnel (KMP) effective May 20, 2026. This decision was made during the Board of Directors meeting held on May 19, 2026, where the board also approved audited financial results, recommended a final dividend of ₹3 per share, and appointed internal and cost auditors for FY 2026-27. Additionally, the board passed an enabling resolution to raise up to ₹500 Crores to support business growth and diversification into areas like drug delivery devices, consumer electronics, and semiconductor components.

Shaily Engineering Plastics Ltd has allotted 40,155 equity shares to eligible employees upon exercising their options under the Shaily Employee Stock Option Plan 2019. The allotment was approved by the Nomination and Remuneration Committee on May 19, 2026, at an exercise price of ₹732/- and ₹684/- per share. Consequently, the issued and paid-up equity share capital increased from ₹9,19,10,186 to ₹9,19,90,496.

The Board of Directors of Shaily Engineering Plastics Ltd, in its meeting held on May 19, 2026, recommended a final dividend of ₹3 per share (150%) for the financial year ended March 31, 2026, subject to shareholder approval. The board also approved the appointment of M/s Jain & Hindocha as the Internal Auditor and M/s YS Thakar & Co as the Cost Auditor for FY 2026-27. Additionally, Mr. Chi Hung Kam was appointed as the Chief Operating Officer – Healthcare and Key Managerial Personnel (KMP). The board passed an enabling resolution to raise funds up to ₹500 Crores through various permissible modes to augment business growth.

Shaily Engineering Plastics Ltd. announced the approval of its audited standalone and consolidated financial results for the year ended March 31, 2026, during a board meeting held on May 19, 2026. The results, reviewed by the Audit Committee, are available on the company's website. The audit report, conducted by BS Rand Co., Chartered Accountants, expresses an unmodified opinion, confirming a true and fair view of the company's financial performance in accordance with regulatory requirements and accounting standards.

Shaily Engineering Plastics Ltd's board approved audited financial results for the year ended March 31, 2026, recommending a final dividend of ₹3 per share. They also approved the appointments of M/s Jain & Hindocha as Internal Auditor and M/s YS Thakar & Co as Cost Auditor for FY 2026-27. Mr. Chi Hung Kam was appointed as Chief Operating Officer – Healthcare and Key Managerial Personnel, effective May 20, 2026. The board passed an enabling resolution to raise funds up to ₹500 Crores through various permissible modes to augment business growth.

Shaily Engineering Plastics Ltd has scheduled a Board of Directors meeting on May 19, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a final dividend for FY26 and discuss enabling resolutions for raising funds through equity or other securities. The trading window closure period is from April 1, 2026, to May 21, 2026.

Shaily Engineering Plastics Ltd responded to BSE and NSE regarding a significant movement in its share price. The exchanges had sought clarification on any information or impending announcements that could influence the price/volume behavior of the company's scrip. Shaily Engineering confirmed that the movement in its share price is purely market-driven. The company also affirmed its compliance with Regulation 30 of the SEBI (LODR) Regulations, 2015, and stated that there are no further material events requiring disclosure beyond what has already been made public.